The core components of telomerase are telomerase RNA (TR) and telomerase reverse transcriptase (TERT). In vertebrate cells, TR and TERT have been reported to associate with intranuclear structures, including Cajal bodies and nucleoli as well as telomeres. Here, we examined the time course of both TR localization and assembly of TR with TERT in Xenopus oocytes. The major trafficking pathway for microinjected TR is through Cajal bodies into the nucleoplasm, with a fraction of TR found in nucleoli at later time points. Telomerase assembly precedes nucleolar localization of TR, and TR mutants that do not localize to nucleoli form active enzyme, indicating that localization of TR to nucleoli is not required for assembly with TERT. Assembly of telomerase coincides with Cajalbody localization; however, assembly is also unaffected by a CAB-box mutation (which significantly reduces association with Cajal bodies), suggesting that Cajal-body localization is not important for assembly. Our results suggest that assembly of TR with TERT occurs in the nucleoplasm. Unexpectedly, however, our experiments reveal that disruption of the CAB box does not eliminate early targeting to Cajal bodies, indicating that a role for Cajal bodies in telomerase assembly cannot be excluded on the basis of existing knowledge.
Introduction
Telomerase is the ribonucleoprotein (RNP) enzyme that functions to maintain the length of telomere DNA in eukaryotic organisms (Greider and Blackburn, 1985) . In humans, telomere maintenance and telomerase activation are crucial steps in cellular immortalization and tumor progression, and the telomerase enzyme is well established as a target for development of cancer therapeutics (Harley, 2008; Shay and Keith, 2008) .
Telomerase RNA (TR) and telomerase reverse transcriptase (TERT) are core components of telomerase. In vitro reconstitution experiments have shown that TR and TERT are sufficient for catalytic activity, indicating that these are the minimal components of telomerase (Autexier et al., 1996; Masutomi et al., 2000; Weinrich et al., 1997) . TERT is a specialized reverse transcriptase that binds TR directly and utilizes a short region in the RNA as a template for the synthesis of telomeric-DNA repeats (Autexier and Lue, 2006; Meyerson et al., 1997; Nakamura et al., 1997) . In general, eukaryotic organisms share highly conserved TERT proteins (Autexier and Lue, 2006 ) that interact with phylogenetically diverse TR molecules (Collins, 2006; Theimer and Feigon, 2006) . Analysis of sequences of TRs from a wide range of eukaryotic species has revealed the evolution of at least three TR classes: ciliate, yeast and vertebrate (Chen et al., 2000; Collins, 1999; Dandjinou et al., 2004; Tzfati et al., 2003) . TRs from all studied organisms share certain essential features (including template sequences and pseudoknot domains) but, in addition, seem to possess class-specific RNA motifs. For example, yeast TRs harbor a domain termed the Sm site, which is also found in small nuclear (sn)RNAs that function in pre-mRNA splicing (Seto et al., 1999; Tzfati et al., 2003) . By contrast, vertebrate TRs contain H/ACA and Cajal body (CAB) motifs, which are characteristic of the small nucleolar (sno) and small Cajal body (sca)RNAs that function in pre-ribosomal RNA and snRNA maturation, respectively (Chen et al., 2000; Darzacq et al., 2002; Jady et al., 2004; Matera et al., 2007; Mitchell et al., 1999a; Terns and Terns, 2006) . Ciliate TRs do not possess recognizable Sm sites, or H/ACA or CAB motifs (Collins, 1999) . The Sm site of yeast TR, and H/ACA and CAB motifs of vertebrate TRs are recognized by distinct sets of known proteins Fu and Collins, 2006; Mitchell et al., 1999b; Pogacic et al., 2000; Seto et al., 1999; Venteicher et al., 2009 ) and seem to provide metabolic stability and nuclear localization to TR (Cristofari et al., 2007; Fu and Collins, 2003; Lukowiak et al., 2001; Mitchell et al., 1999a; Teixeira et al., 2002) . The proteins that bind these domains are not required for telomerase activity in vitro (Autexier et al., 1996; Beattie et al., 1998; Mitchell and Collins, 2000; Tesmer et al., 1999) , but are essential for activity in the cell (Cristofari et al., 2007; Fu and Collins, 2003; Theimer et al., 2007; Venteicher et al., 2009) .
It is clear that, following their initial synthesis, TR and TERT must be assembled together to form a functional enzyme. However, we are only beginning to understand the pathways by which vertebrate telomerase is transported, assembled and regulated. Previous studies implicate two intranuclear structures in telomerase trafficking: Cajal bodies and nucleoli.
The first clear evidence that TR associates with Cajal bodies and nucleoli came from Xenopus oocytes, in which it was found that microinjected TR localizes to both structures (Lukowiak et al., 2001; Narayanan et al., 1999a) . The localization of TR to nucleoli is dependent on the H/ACA motif (Lukowiak et al., 2001) , which is also responsible for the nucleolar localization of snoRNAs (Narayanan et al., 1999a) . In human cells, the localization of endogenous TR has been examined by fluorescence in situ hybridization (FISH) (Jady et al., 2004; Jady et al., 2006; Theimer et al., 2007; Tomlinson et al., 2008; Tomlinson et al., 2006; Telomerase trafficking and assembly in Xenopus oocytes al., 2004) . In human cancer cells (but not primary cells), TR accumulates in Cajal bodies in interphase cells (Cristofari et al., 2007; Jady et al., 2004; Jady et al., 2006; Tomlinson et al., 2006; Venteicher et al., 2009; Zhu et al., 2004) . Specifically in S phase of the cell cycle, TR shifts from Cajal-body localization to localization to a subset of telomeres (Jady et al., 2006; Tomlinson et al., 2008; Tomlinson et al., 2006) . A fraction of endogenous TR also localizes to the surface of nucleoli (Tomlinson et al., 2006) specifically during early S phase. Biochemical analysis also detected a small fraction of TR associated with nucleoli of human cancer cells (Mitchell et al., 1999a) . The localization of TR to both Cajal bodies and telomeres is dependent upon expression of TERT (Tomlinson et al., 2008; Tomlinson et al., 2006) as well as another vertebrate telomerase subunit, TCAB1 (Cristofari et al., 2007; Tycowski et al., 2009; Venteicher et al., 2009) .
TERT has also been found associated with both nucleoli and Cajal bodies. Ectopically expressed and GFP-tagged TERT exhibits a prominent nucleolar localization in mammalian cells (Etheridge et al., 2002; Wong et al., 2002; Yang et al., 2002) and a less obvious association with Cajal bodies (Zhu et al., 2004) . However, examination of endogenous TERT by immunofluorescence analysis in cancer cells reveals a significantly different pattern. During most of the cell cycle, TERT is found in intranuclear foci that are not associated with nucleoli or Cajal bodies (Tomlinson et al., 2006) . In early S phase, a fraction of TERT moves into the nucleolus and, in mid-S phase, TERT (similar to TR) is found in Cajal-bodyassociated foci and at telomeres (Tomlinson et al., 2006) .
In each of these previous studies, localization patterns of TR and TERT were examined under steady-state conditions; the initial pathway traveled by nascent TR was not addressed. In this study, we have used the Xenopus oocyte system to investigate the time course of both the localization of Xenopus TR and assembly of telomerase following microinjection. The oocyte is unique in its capacity to provide this kind of dual analysis of newly introduced molecules (Terns and Goldfarb, 1998) . The results indicate that assembly of TR and TERT does not require nucleolar localization, and suggest that assembly also does not require localization to the Cajal body but more probably occurs in the nucleoplasm, where the assembled complexes accumulate and the endogenous enzyme resides in stage-VI prophase-arrested Xenopus oocytes.
Results

TR assembles into a functional enzyme following injection into Xenopus oocytes
Previously, we have shown that TR is retained within the nucleus and associates with both Cajal bodies and nucleoli following injection into Xenopus oocyte nuclei (Lukowiak et al., 2001; Narayanan et al., 1999a ). Here, we tested whether microinjected Xenopus TR (xTR) is incorporated into functional telomerase complexes in oocytes (Fig. 1) . Telomerase assembly was determined using a standard, PCR-based telomeric-repeat amplification protocol (TRAP) assay that measures addition of telomeric repeats (by assembled telomerase) to a defined oligonucleotide primer in vitro (Wright et al., 1995) . Telomerase activity is detected as a ladder of products incrementally larger than the primer. To specifically assay the activity of the injected xTR (and not the activity of endogenous telomerase), we altered the template region (see Fig. 1A ) of xTR (AATCCC to AAACCC) and used reaction conditions and primers specific for the unique telomeric repeats that would be synthesized by the altered-template xTR (TTTGGG rather than TTAGGG) (Feng et al., 1995) . Using this modified set of conditions, the activity of endogenous (wildtype template) telomerase was not detected, even when an equivalent amount of wild-type-template xTR is injected (Fig. 1B , lanes 1 and 2). Activity was detected following injection of the altered-template xTR (Fig. 1B, lane 3) , and is sensitive to RNAse treatment (Fig. 1B, lane 4) . The resulting TRAP-assay products were sequenced to verify that the products were derived from the injected, altered-template xTR (data not shown). In addition, we performed control experiments to ensure that the telomerase activity that we detect in injected oocytes reflects enzyme assembled in vivo and not in vitro under the TRAP-assay conditions. Mixing the altered-template xTR with (uninjected) nuclear extract did not result in assembly of the RNA into an active enzyme in vitro (Fig.  1C, lane 2) . In addition, the activity of the altered-template xTR was not affected by the addition of wild-type competitor RNA in vitro (data not shown). Therefore, the telomerase activity that we detected represents the assembly of exogenous TR with endogenous TERT in vivo (Fig. 1C, lane 3) . Thus, the assay is specific for activity of the injected TR and, moreover, the injected TR assembles with TERT in the oocyte to form functional telomerase complexes.
Injected xTR moves rapidly through Cajal bodies into the nucleoplasm
Our finding that injected xTR assembles into functional telomerase complexes allowed us to address when and where the RNA assembles with TERT by examining the time course of both movement and activity of the injected molecules. The general strategy is illustrated in Fig. 2A . Nuclei were isolated from oocytes over an extensive time course following injection of labeled xTR into nuclei. At each time point we assayed the following: (1) the (Chen et al., 2000) . Substitution mutations were made in the template region, and the box H and box ACA of the box-H/ACA motif. (B)Injected xTR associates with endogenous xTERT to form active enzyme. Alteredtemplate xTR was injected into oocytes and a modified TRAP assay specific to this injected xTR was performed. Internal control for PCR reaction is indicated (IC). Activity (ladder of bands above IC) is observed upon injection of this xTR (Alt. template) and is lost with RNAse A treatment (RNAse). Using the modified TRAP assay, activity was not detected in uninjected cells (uninjected) or in cells injected with xTR containing a wild-type template (WT). (C)Assembly occurs in vivo, not in vitro. Altered-template xTR was injected into Xenopus oocytes and the nuclei were dissected 1 hour after injection and transferred to lysis buffer (in vivo). The same amount of RNA was added into lysis buffer and incubated on ice for 30 minutes with uninjected nuclei (in vitro). The modified TRAP assay was performed on these lysates and uninjected control lysate (uninjected).
percentage of injected xTR in intranuclear structures versus in the nucleoplasm (via biochemical fractionation), (2) localization of the injected RNA relative to specific nuclear structures (via microscopy of nuclear spreads) and (3) the extent to which the injected RNA had assembled into a functional RNP (via the modified TRAP assay described above).
To directly assess the amount of xTR found in the nucleoplasm and nuclear structures as a function of time following injection, we microinjected radiolabeled xTR into Xenopus oocyte nuclei and, at various time points, fractionated the nucleus into structures and nucleoplasm (by centrifugation). Over a 72-hour time course, we followed the distribution of xTR and two co-injected control RNAs (U3 snoRNA and U1 snRNA). As expected, U3 snoRNA moved gradually from the nucleoplasm to structures [Cajal bodies and later nucleoli (see Narayanan et al., 1999b) ], whereas the majority of U1 snRNA was found in the nucleoplasm at all time points (Fig.  2B ,C). [Endogenous U1 snRNA fractionates with the nucleoplasm (Lukowiak et al., 2001 ) and injected U1 snRNA does not localize to either Cajal bodies or nucleoli (Narayanan et al., 1999a; Narayanan et al., 1999b) .] We found that xTR undergoes a rapid association with nuclear structures and then eventually moves to the nucleoplasm (Fig. 2B,C) . At the earliest time point that we examined (30 minutes after injection), most of the xTR (but very little U3 or U1 RNA) was found in the pelleted structures. By approximately 8 hours after injection, most of the xTR was in the nucleoplasmic fraction, where it eventually seemed to reach a steady-state level of 70-80%, similar to that observed for the endogenous xTR (Lukowiak et al., 2001) . Similar temporal profiles were observed using injected RNA amounts ranging between 0.01 and 1.0 fmol (femtomole) of xTR (data not shown).
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To determine which structures the RNA is associated with at the various points in the time course, we followed fluorescently labeled xTRs via microscopy ( Fig. 3) . Control experiments clearly demonstrated that our method of labeling xTR with fluorescein [by transcription with fluorescein-12-uridine-5Ј-triphosphate (UTP)] does not significantly alter any of the biological properties of the RNA that we examined, which included stability, nuclear retention, biochemical fractionation and assembly into functional telomerase (Lukowiak et al., 2001; Narayanan et al., 1999b) (and this study). Using this approach, we had previously found that xTR localized to both Cajal bodies and the dense fibrillar subcompartment of nucleoli (Lukowiak et al., 2001) . Each oocyte nucleus contains approximately 50-100 Cajal bodies and as many as 1500 nucleoli (Gall et al., 2004) . Technical improvements have allowed us to inject less RNA (1 fmol instead of 3 fmols) than in the earlier work, providing better resolution in the time course. At early time points (30 minutes, Fig. 3 ; and also 15 minutes, data not shown), xTR is strongly associated with Cajal bodies (immunostained with antibodies against the Cajal-body marker protein coilin and indicated by arrows in Fig. 3 ). No signal was observed in nucleoli (the larger structures visible in the fields in Fig. 3 ) at the early time points. At later time points, the signal in Cajal bodies decreases and thereafter remains at a low level that is nevertheless significantly above background signals seen in uninjected oocytes (see Fig. 3 , top set of panels). At later time points (24-48 hours), we also observed localization of the RNA to nucleoli. These results indicate that the majority of xTR moves through Cajal bodies at early time points following injection. A small fraction of xTR remains stably in Cajal bodies throughout the time course and appears in nucleoli at later time points. P-labeled xTR and control RNAs U3 and U1 were co-injected into oocyte nuclei. The nuclei were obtained and biochemical fractionation was performed at the indicated time points. The RNAs present in structural (pellet) and nucleoplasmic (supernatant) fractions are shown. U3 is a snoRNA that stably associates with nucleoli. U1 is a snRNA found primarily in the nucleoplasm. (C)Graph of the distribution of xTR with relation to U3 and U1 control RNAs. The results in B were quantitated and the percent (%) of each indicated RNA found in the pellet is graphed relative to time (in hours) after injection. The results of three independent experiments are plotted; error bars indicate the standard deviation.
Fig. 3. xTR rapidly localizes to Cajal bodies following injection into
Xenopus oocytes. Fluorescein-labeled xTR (xTR panels) was injected (1 fmol/cell) and nuclear spreads were prepared at the indicated time points (hours) after injection. Cajal bodies were immunostained with anti-coilin antibodies (coilin panels) and are indicated with arrowheads. Uninj, uninjected nucleus; DIC, differential interference contrast. The larger structures present in the DIC field are nucleoli. Scale bar: 10m.
The temporal pattern of xTR localization in nuclear structures (Fig. 3) is in good agreement with the results of the biochemical fractionation experiments (Fig. 2) . The early and transient association of the majority of xTR with nuclear structures (Fig. 2) seems to be attributable to localization to Cajal bodies (Fig. 3) . At later time points, the small fraction of xTR that is associated with structures ( Fig. 2) can be found in both Cajal bodies and nucleoli (Fig. 3 ).
Nucleolar localization and the H/ACA motif of TR are not essential for assembly of TR and TERT in vivo
To address whether localization of xTR to the nucleolus is required for telomerase assembly, we made mutations in elements (the box-H/ACA motif) of xTR that are known to be required for nucleolar localization (Lukowiak et al., 2001) . The box-H/ACA motif was first recognized in snoRNAs and is responsible for targeting these RNAs to the nucleolus (Lange et al., 1999; Narayanan et al., 1999a) . We had previously shown that mutations in the H/ACA motif (box H or box ACA, see Fig. 1A ) prevent localization of TR to nucleoli (Lukowiak et al., 2001) . In order to specifically address whether nucleolar localization is essential for telomerase assembly, we tested the effect of mutations in box H and box ACA on the ability of the altered-template xTR to assemble with TERT into a functional complex. We found that both H/ACA-motif mutants formed functional complexes (Fig. 4A , compare H and ACA to uninjected). However, the level of activity found with the H/ACA mutants was less than that observed with the wild-type RNA, particularly at early time points (Fig. 4A , compare H and ACA to WT at 1 hour and 3 hours). Mutations in the H/ACA motif greatly reduce the nuclear retention of TR (resulting in loss of TR to the cytoplasm) and also decrease the stability of the RNA (Lukowiak 2467 Telomerase assembly in Xenopus oocytes et al., 2001) . Thus, the amounts of the H/ACA-mutant RNAs present in the nucleus at the times when activity was assayed were significantly less than the amount of control wild-type RNA (Fig.  4B ). To better compare the RNAs, we assayed a range of wild-type xTR concentrations, identified samples that produced telomerase activity similar to the mutant (Fig. 4C, arrows) and examined the corresponding amounts of RNA present in the nucleus at the time of assay (Fig. 4C, lower panel) . We found that the amount of RNA required to produce equivalent levels of telomerase activity was tenfold more for mutant than wild-type xTR at 1 hour after injection, but only ~threefold more mutant than wild-type xTR was required at 3 hours, indicating that the H/ACA-mutant RNA assembles more slowly. As we have previously reported, we did not detect localization of the H/ACA mutants in nucleoli (Lukowiak et al., 2001) ; however, similar to wild-type xTR, the H/ACA mutants did associate with Cajal bodies (Fig. 4D) . Thus, nucleolar localization of xTR is not essential for assembly of a functional TR-TERT complex, and the ability to form functional telomerase complexes in vivo does not require an intact H/ACA motif.
Assembly of TR-TERT is coincident with localization of TR to Cajal bodies (and precedes localization to nucleoli)
A point of great interest is when and where in the cell telomerase is assembled into an active enzyme. Using the Xenopus oocyte system, we can assess the assembly of the injected (altered template) xTR with TERT by the modified TRAP assay (Fig. 1 ) over time and relate the timing of assembly to the location of the RNA. Fig.  5A shows the telomerase activity associated with the injected xTR over an extensive time course. We observed significant telomerase activity as early as 15 minutes after injection, indicating that the RNA is quickly assembled with TERT into a functional complex. Oocyte nuclei were harvested 1 and 3 hours after injection of 32 P-labeled altered-template wild-type (WT) and mutant (H and ACA) xTRs. The nuclear extract was then subjected to the modified TRAP assay. IC, internal control for TRAP assay; -, no lysate control; uninj, uninjected nuclei. (B)Box-H-and box-ACA-mutant xTRs are less stable than wild-type xTR. The RNAs present in the oocyte nuclei from A were isolated and analyzed by gel electrophoresis. U3 served as an injection and loading control. M, marker for amount of RNA injected. (C)Box-ACA-mutant xTR is assembled into active telomerase complexes more slowly than wild-type xTR. Box-ACA-mutant xTR (1 fmol/cell) and a range of levels of wild-type xTR (1, 0.2, 0.04 and 0.01 fmol/cell) were injected into Xenopus nuclei (all RNAs had altered template regions). The nuclei were isolated at 1 and 3 hours after injection and modified TRAP assays were performed on the nuclear lysates. At each time, RNAs were extracted and analyzed by gel electrophoresis (bottom panel). Arrows denote levels of wild-type and box-ACA-mutant RNA that produce comparable activity at 1 and 3 hours. (D)Box-H/ACA-mutant xTRs do not localize to nucleoli, but do associate with Cajal bodies. Fluorescently labeled wild-type (WT panels) or mutant (H and ACA panels) xTR was injected into Xenopus oocytes (2 fmol/cell) and nuclear spreads were prepared 1 hour after injection (xTR panels). Cajal bodies were immunostained with anti-coilin antibodies (coilin panels) and are indicated with arrowheads. DIC, differential interference contrast. The large spherical structures seen in the DIC panels correspond to nucleoli. Scale bar: 10m.
The kinetics of telomerase assembly (early) corresponds to the timing of Cajal-body localization, but are incongruent with the kinetics of nucleolar localization (late) (see Fig. 3 ).
The coincidence of assembly of TR and TERT with the transit of xTR through the Cajal body suggests a model in which xTR is assembled with TERT in the Cajal body (and then the newly made complex moves to the nucleoplasm). To test this idea, we next examined telomerase activity in the nucleoplasm and nuclear structures over the time course. Following injection of the alteredtemplate xTR, oocyte nuclei were fractionated into structures and nucleoplasm (by centrifugation) at various time points and modified TRAP assays were performed. We found that the telomerase complex formed by the injected xTR fractionates with the nucleoplasm (supernatant) rather than structures (pellet) at all time points examined (Fig. 5A) . These results suggest that telomerase assembly takes place in the nucleoplasm although it remains possible that assembly occurs within Cajal bodies with rapid transit out of these structures following assembly.
Analysis of the localization of endogenous telomerase indicated that essentially all steady-state activity was observed in the nucleoplasmic fraction (Fig. 5B, upper panel) . No activity was detected in association with the small fraction of endogenous xTR found in nuclear structures at steady state (Fig. 5B, lower panel) . Together, these results indicate that active telomerase resides in the nucleoplasm of Xenopus oocytes and that the enzyme that is assembled from the injected TR reaches a similar steady-state distribution as endogenous telomerase.
Disruption of the CAB box of TR reduces association of TR with Cajal bodies but does not impair assembly with TERT
In human cells, mutation of the CAB box results in a shift in the site of the steady-state accumulation of TR from Cajal bodies to nucleoli (Cristofari et al., 2007; Jady et al., 2004) . We mutated the CAB box of xTR with the expectation that the mutation would prevent localization of the RNA to Cajal bodies and allow us to assess the importance of Cajal-body localization in telomerase assembly. Disruption of the CAB box did not result in a loss of stability or nuclear retention of the RNA, and did not affect assembly with TERT (Fig. 6A,B) . The same level of activity was 2468 Journal of Cell Science 123 (14) observed with both the injected CAB-box-mutant and wild-type RNA (Fig. 6A) , consistent with findings in human cells (Cristofari et al., 2007; Fu and Collins, 2006) . However, we found that, although disruption of the CAB box significantly reduced the extent of Cajal-body localization observed at later time points, it did not prevent association. The CAB-box mutant was strongly associated with Cajal bodies at early time points, similar to wildtype xTR (Fig. 6C) . Disruption of the CAB box increases both the speed and extent of association of TR with nucleoli (Fig. 6B,C) . The localization profile of CAB-box-mutant xTR observed at later time points is consistent with the steady-state localization profile observed in human cells, wherein most CAB-box-mutant human TR accumulates in nucleoli rather than in Cajal bodies (Cristofari et al., 2007; Jady et al., 2004) . The reduction in Cajal-body association caused by disruption of the CAB box did not impair assembly of TR-TERT complexes, suggesting that Cajal-body localization is not important in this aspect of telomerase biogenesis. However, these studies reveal that disruption of the CAB box might not prevent transient association of TR with Cajal bodies, and suggest that a role for Cajal bodies in telomerase assembly cannot be excluded on the basis of existing knowledge.
Discussion
Understanding how the telomerase enzyme is assembled in vivo from its component parts is crucial towards understanding telomerase function and regulation, and might contribute to efforts aimed at combating cancer by interfering with telomerase function (Harley, 2008; Shay and Wright, 2002) . All vertebrate cells contain telomerase complexes composed of structurally related TR and TERT molecules that add TTAGGG repeats to chromosome termini (Chen et al., 2000; Moyzis et al., 1988) . Likewise, conserved biogenesis strategies are very probably employed in different vertebrate cell types. Recent studies from our laboratory and others indicate that telomerase trafficking is a cell-cycle-dependent, wellregulated process (Jady et al., 2006; Tomlinson et al., 2008; Tomlinson et al., 2006) . However, these studies only assess localization of telomerase components under steady-state conditions. The work described here demonstrates that Xenopus oocytes offer a powerful in vivo system for the analysis of The resulting supernatants and pellets were subjected to modified TRAP assay (specific for the injected xTR). Unfractionated nuclear extracts (total) were analyzed in tandem. -, negative control (no lysate); uninj, uninjected oocytes; IC, internal control for TRAP assay. (B)Endogenous telomerase activity resides in the nucleoplasm. Uninjected nuclei were fractionated, and telomerase activity in the pellet (P) and supernatant (S) were detected using the standard TRAP assay. Activity in total (not fractionated) extract (T) was analyzed as well. The distribution of xTR, U3 and U1 RNAs from the same fractionation was visualized by northern analysis in the bottom panel.
vertebrate telomerase biogenesis and trafficking. We have analyzed the intranuclear distribution, localization and activity of wild-type and mutant xTR molecules as a function of time spent in living oocytes. These studies indicate that assembly of TR and TERT does not occur in nucleoli. The results also suggest that Cajal-body localization is not important for TR-TERT assembly, but reveal an important caveat to this conclusion in this and other similar studies.
Cajal bodies and the biogenesis of telomerase
Cajal bodies are spherical intranuclear bodies discovered over 100 years ago in neurons by the Spanish scientist Ramon y Cajal (Cajal, 1903) that have since been shown to be common to plant and animal cells (Gall, 2000) , with homologous structures also found in yeast cells . A number of findings have provided a collective view that Cajal bodies serve as centers of post-transcriptional RNA modification (Jady et al., 2003; Verheggen et al., 2002) and RNP assembly for a variety of nuclear complexes (Carmo-Fonseca, 2002; Gall, 2003; Kaiser et al., 2008; Morris, 2008; Terns and Terns, 2001) . Previous findings in mammalian cells (Cristofari et al., 2007; Jady et al., 2004; Theimer et al., 2007; Tomlinson et al., 2008; Venteicher et al., 2009; Zhu et al., 2004) point to the Cajal body as a conserved site along the pathway of vertebrate telomerase biogenesis and function; however, the functional significance of the localization of TR to Cajal bodies is not known.
A multitude of possible telomerase biogenesis steps can be envisioned to occur within Cajal bodies consistent with the known or proposed functions of this nuclear structure. For example, given that several snRNAs seem to undergo their post-transcriptional modification within Cajal bodies (Jady et al., 2003) , it follows that Cajal bodies might be sites where TR is modified [by the 5Ј-cap hypermethylase (Jady et al., 2004) or predicted scaRNAs that guide putative site-specific TR nucleotide modifications, although, to date, no such modifications have been mapped and reported for TR]. In addition, several lines of evidence indicate that specific steps of telomerase RNP assembly occur at Cajal bodies. For example, the finding that both TR (Figs 3, 4) (Cristofari et al., 2007; Jady et al., 2004; Lukowiak et al., 2001; Theimer et al., 2007; Tomlinson et al., 2008; Tomlinson et al., 2006; Tycowski et al., 2009; Venteicher et al., 2009; Zhu et al., 2004) and several telomerase protein components, including proteins that recognize the box-H/ACA domain or CAB-box element of TR, localize to Cajal bodies (Cohen et al., 2007; Matera et al., 2007; Tycowski et al., 2009; Venteicher et al., 2009; Zhu et al., 2004) is consistent with the proposal that these components are joined into telomerase RNP complexes in this nuclear body. Recently, it was found that human TR interacts with the TCAB1 protein (which resides at Cajal bodies) in order to become recruited to, and function at, telomeres (Venteicher et al., 2009) .
It is less clear when and where TERT joins nascent TR in such a proposed multi-step, telomerase-RNP biogenesis pathway. Consistent with the possibility that TERT-TR interaction occurs within Cajal bodies is our observation that the assembly of TR into active telomerase enzyme in Xenopus oocytes occurs with kinetics comparable to the association of the RNA with Cajal bodies (Figs  3-5) . Furthermore, in mammalian cells, the accumulation of TR at Cajal bodies correlates with the capacity of the cells to assemble active telomerase enzyme. Specifically, TR accumulates in the Cajal bodies of a variety of cancer cell lines (where functional telomerase assembly is ongoing) but not primary cell lines (where little to no telomerase is being made) (Jady et al., 2004; Zhu et al., 2004) . Ectopic expression of human TERT in primary cells reinstates telomerase assembly and leads to accumulation of TR in Cajal bodies (Tomlinson et al., 2008; Zhu et al., 2004) . Data also suggests that the assembly of telomerase might be mediated by a chaperone of RNP assembly that selectively localizes to Cajal bodies within the nucleus -the survival of motor neuron (SMN) complex (Paushkin et al., 2002; Terns and Terns, 2001; Whitehead et al., 2002) . Although our results are consistent with a model Fig. 6 . CAB-box-mutant xTR assembles with endogenous TERT and associates transiently with Cajal bodies. (A)The CAB-box mutant is retained within the nucleus and assembles with TERT. A total of 1 fmol of wild-type (WT) or CAB-motif-mutant (CAB) xTR was injected into the nuclei of Xenopus oocytes. (Both RNAs contained the mutant template region.) The activity (detected by modified TRAP assay, top panel), stability and nucleocytoplasmic distribution (bottom panel) of each RNA was analyzed 1 hour after injection. U3 RNA serves as an injection and loading control. Uninj, uninjected oocyte; IC, internal control; M, marker for amount of RNA injected; N, nuclear; C, cytoplasmic. (B)The subnuclear distribution of CABbox-mutant xTR varies from that of wild type. Wild-type (WT) or CAB-boxmutant (CAB) xTR was co-injected with U3 and U1 control RNAs. Biochemical fractionation experiments were performed as described in Fig. 2 . The percentage of each RNA present in the pelleted fraction (corresponding to subnuclear structures) is plotted versus time following injection (in hours). The graph represents the results of two independent experiments; error bars indicate standard deviation. (C)CAB-box-mutant xTR initially localizes to Cajal bodies prior to associating with nucleoli. A total of 1 fmol of fluorescently labeled wild-type or CAB-box-mutant xTR was injected (xTR panels). Nuclear spreads were prepared 1 and 6 hours after injection (as indicated). Cajal bodies were immunostained with anti-coilin antibodies (coilin panels, denoted by arrowheads). Uninj, uninjected nuclei; DIC, differential interference contrast. The larger spherical structures present in the DIC panel are nucleoli. Scale bar: 10m.
wherein telomerase assembly occurs within Cajal bodies (followed by a rapid export of the assembled complexes to the nucleoplasm), our data favors a model in which TR-TERT assembly occurs in the nucleoplasm. This scenario is suggested by our observation that newly assembled functional TR-TERT telomerase complexes are detected primarily in nucleoplasmic rather than Cajal-bodycontaining fractions over an extensive time course (Fig. 5) . In addition, when Cajal-body-association of TR is reduced by mutation of the TR CAB box or depletion of TCAB1, the assembly of TR and TERT is not noticeably impaired (Cristofari et al., 2007; Fu and Collins, 2006; Venteicher et al., 2009 ). However, our detailed temporal analysis of the xTR CAB-box mutant uncovered an important caveat. We introduced the same CAB-box mutation shown to dramatically impair Cajal-body localization (and enhance nucleolar association) in human cells (Cristofari et al., 2007; Jady et al., 2004) and obtained similar results regarding steady-state localization and ability to assemble with TERT, but found that the mutation did not prevent initial targeting of TR to Cajal bodies (Fig. 6 ). Our data suggest that the CAB box of TR [and the protein that interacts with the CAB box of TR and other CAB-boxcontaining scaRNAs, TCAB1 (Tycowski et al., 2009; Venteicher et al., 2009) ] might be involved in Cajal-body TR retention (or prevention of nucleolar localization) rather than in Cajal-body targeting. In addition, our findings re-emphasize the limitations of conclusions that, based on analysis of disruption of CAB-boxmediated localization of TR, exclude a potential role of the Cajal body in assembly.
A role for nucleoli in telomerase biogenesis?
The findings that both TR (Lukowiak et al., 2001; Mitchell et al., 1999a) and TERT (Etheridge et al., 2002; Tomlinson et al., 2006; Wong et al., 2002; Yang et al., 2002) are detected at nucleoli (at least in specific cell types under certain conditions) have led to the idea that telomerase assembly takes place within nucleoli. However, our results suggest that the nucleolus is not the site where TR and TERT form an active telomerase enzyme. We have found that detection of telomerase catalytic activity precedes the appearance of injected TR in nucleoli by a number of hours (Figs 3, 5) . Furthermore, disruption of the box-H/ACA motif, which prevents the nucleolar localization of TR (Lukowiak et al., 2001) , does not prevent TR association with either Cajal bodies or Xenopus TERT in vivo (Fig. 4) .
We show that little or no endogenous TR is present in nucleoli of Xenopus oocytes under steady-state conditions (Fig. 4B ), but that a small fraction of injected TR is targeted to nucleoli at very late times after injection (Figs 3, 4 ). Although it is formally possible that the nucleolar localization of injected TR reflects a late step in telomerase biogenesis [e.g. TR modification or association of regulatory protein(s)], it is also possible that TR associates with nucleoli only when TR levels are in excess of that which can be accommodated by factors of the telomerase biogenesis pathway. Consistent with this possibility, TR appears at oocyte nucleoli at early time points if the levels of injected TR are increased (Lukowiak et al., 2001) . Similarly, ectopic overexpression of GFPtagged TERT in human cells leads to localization of the protein in nucleoli (Etheridge et al., 2002; Wong et al., 2002; Yang et al., 2002) , but endogenous human TERT primarily resides in nuclear foci that are distinct from nucleoli (Tomlinson et al., 2006) . Biochemical fractionation data also indicate that the vast majority of TR does not reside in nucleoli in human cells (Mitchell et al., 1999a) .
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Although the data presented here suggest that the nucleolus is not the site of TR-TERT interaction, nucleoli might be important for cell-cycle-dependent steps of telomerase holoenzyme formation or in regulating telomerase activity and recruitment to telomeres. The nucleolus is known to orchestrate a number of cellular functions beyond ribosome biogenesis, including cell-cycle regulation, viral replication, regulation of cellular survival and proliferation (Boisvert et al., 2007; Pederson and Tsai, 2009 ). Analysis of the nucleolar proteome has revealed dynamic associations of specific proteins with nucleoli in response to changes in metabolism or at specific phases of the cell cycle (Boisvert et al., 2007; Leung and Lamond, 2003) . Our own work has shown that endogenous TR and TERT both transit to nucleoli in a cell-cycle-dependent manner that precedes localization to telomeres (Tomlinson et al., 2006) . Furthermore, localization studies suggest that the intranuclear distribution of ectopically expressed GFP-tagged TERT shifts between the nucleolus and the nucleoplasm in response to cellcycle phase, expression of viral oncogenes and ionization-induced double-stranded DNA breaks (Wong et al., 2002) .
Although an intact H/ACA domain is not essential for targeting TR to the Cajal body or for assembly of TR and TERT in vivo, the rate of telomerase assembly is reduced by box-H/ACA mutations. This observation suggests that proteins that recognize the H/ACA motif (i.e. dyskerin, GAR1, Nhp2 and Nop10) or nearby CAB-box domain (i.e. TCAB1) might help recruit or stabilize TERT binding in vivo or that the H/ACA motif helps stabilize the RNA in a conformation that more favorably binds TERT.
Finally, future experiments are required to gain a deeper understanding of molecular mechanisms responsible for proper assembly and trafficking of telomerase. Telomerase plays a crucial role in genome stability and tissue renewal through maintenance of telomere length in the face of inevitable replication-dependent shortening. Misregulation of telomerase activity underlies common and serious human diseases. For example, telomerase activation is a nearly universal hallmark of human cancer (Harley, 2008; Shay and Keith, 2008) . By contrast, telomerase deficiency is responsible for a series of life-threatening genetic diseases (Aubert and Lansdorp, 2008; Blasco, 2007; Garcia et al., 2007) . Understanding how telomerase activity is regulated in vivo will provide insight into how the enzyme might be manipulated to combat these devastating human diseases. The Xenopus oocyte system established in this work has the potential to provide important insight into aspects of the regulated trafficking and assembly of telomerase in vertebrate cells.
Materials and Methods
Constructs
Wild-type xTR, U3 and U1 constructs were previously described (Lukowiak et al., 2001) . The altered-template xTR (TTAGGG changed to TTTGGG) was generated by PCR using the wild-type gene encoding xTR as the template and primers 5Ј-GAATCAGCGTTTAAAGCTCAATGTGGACGGAGGTCTCTGTTTCGCAAAC -CCAAATACACTGGC-3Ј and 5Ј-ACATGTCGGGGACTGGCTG-3Ј. All other mutant TRs were generated by PCR using the altered-template xTR construct as the template. The box-ACA xTR mutant (ACA changed to CCC) was generated using primers: 5Ј-ATTTAGGTGACACTATAGAATCAGCGTTTAAAGCTCAATG-3Ј and 5Ј-ACAGGGCGGGGACTGGCTGAAC-3Ј, box-H xTR mutant (AGAAAA to UGUAUU) using primers 5Ј-GTCGGGTGTATTTAGGGGGCGCGCTGGTG-3Ј and 5Ј-CCCCCTAAATACACCCGACCCCCCAGAC-3Ј, and CAB-box xTR mutant [UUAG (nt.) to UUUC] using primers 5Ј-GTCATGCTTTCCCTTTCTTGTGG-3Ј and 5Ј-CCACAAGAAAGGGAAAGCATGAC-3Ј. All constructs were cloned and their sequences confirmed.
In vitro transcription
In vitro transcription was performed using 100 ng of PCR product in a standard 10 l reaction (Lukowiak et al., 2001 GpppG cap was used instead of the 500 M used in our standard reaction.
Oocyte microinjection, nuclear spreads and microscope analysis
RNAs were microinjected into stage V and VI Xenopus oocyte nuclei as described (Narayanan et al., 1999b) . Briefly, 10 nl solution containing in vitro transcribed RNAs were microinjected into each nucleus. Following injection, the oocytes were cultured at 18°C in 1ϫ MBSH [88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 20 mM HEPES, pH 7.5, 0.82 mM MgSO 4 , 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , containing 10 g/ml penicillin and streptomycin] throughout the time course. At different time points after injection, the cells were manually dissected and the nuclei were removed and used for either biochemical fractionation (see below), TRAP assays (also below) or nuclear spreads. Nuclear spreads were prepared essentially as described (Lukowiak et al., 2001) . To detect Cajal bodies, indirect immunofluorescence was performed using a polyclonal antibody against Xenopus p80 coilin (R31, 1:5000 dilution) and Texas-Red-conjugated anti-rabbit secondary antibody (1:100 dilution, Jackson ImmunoResearch, West Grove, PA). Images were obtained on a Zeiss Axiovert S 100 inverted fluorescence microscope equipped with differential interference contrast (DIC) optics (Carl Zeiss, Thornwood, NY). All images were acquired at 63ϫ magnification using a cooled charge-coupled device camera (Quantix-Photometrix, Tucson, AZ) and IP Lab Spectrum software (Signal Analytics, Fairfax, VA).
Biochemical fractionation and northern blotting
At each time point at least three to five nuclei were transferred to 50-100 l D250 solution (50 mM Tris-HCl, pH 7.6, 25 mM KCl, 10 mM MgCl 2 , 250 mM sucrose and 3 mM fresh DTT) on ice, and the nuclear membranes were destroyed by pipetting 20 times with a 200 l pipette. The nuclear contents were then fractionated at 20,000 g for 15 minutes at 4°C. After the supernatant was transferred to another tube, the pellet was resuspended in an equivalent volume of D250. The RNAs in each fraction were then extracted using standard methods and separated by denaturing PAGE. The gels were dried and exposed to a phosphorimager screen. A northern blot to detect endogenous xTR distribution (Fig. 5B ) was performed using methods and radiolabeled probes as described previously (Lukowiak et al., 2001) . All data was visualized using a phosphorimager (Amersham/GE Healthcare, Little Chalfont, Buckinghamshire, UK) and quantitated using ImageQuant software (Molecular Dynamics/GE Healthcare).
Telomerase extraction and activity assay
Nuclei were isolated and directly transferred into CHAPS lysis buffer (10 mM TrisHCl, pH 7.5, 1 mM MgCl 2 , 1 mM EGTA, 0.1 mM benzamidine, 5 mM bmercaptoethanol, 0.5% CHAPS, 10% glycerol). The nuclear membrane was disrupted by repeated pipetting. The solution was placed on ice for 30 minutes and then centrifuged at 10,000 g for 10 minutes at 4°C. The supernatant was transferred to another tube, frozen and kept at -80°C for future use. When TRAP assays followed biochemical fractionation, equal amounts of solutions from pellet or supernatant were transferred to lysis buffer and incubated on ice, using the same conditions performed on total nuclei. For detection of endogenous telomerase activity (Fig. 5B) , the TRAPeze Telomerase detection kit (Chemicon/Millipore, Temecula, CA) was used. To detect activity from the injected altered-template xTR, the TRAP assay was modified as in Feng et al. (Feng et al., 1995) . The extension of altered-templatetelomerase assay was performed at 30°C for 30 minutes to 1 hour in 15 l total volume in the absence of dATP and dCTP nucleotides. The lysate was heat treated to eliminate the telomerase activity and 1-5 l extension product was used for PCR amplification using a primer specific for these extension products (5Ј-CCG -CGAAACCCAAACCCAAACCCA-3Ј) instead of the wild-type comeback primer provided by the kit.
